The FDA announced that more than 233,003 bottles of duloxetine were recalled on November 19 after finding the capsules contained high levels of N-nitroso-duloxetine. The chemical is an impurity ...

In layman's terms, N-nitroso-duloxetine simply refers to a specific impurity that can be found in duloxetine. It is a type of nitrosamine specific to duloxetine and can be introduced via the ...

The FDA announced that more than 233,003 bottles of duloxetine were recalled on November 19 after finding the capsules contained high levels of N-nitroso-duloxetine. The chemical is an impurity ...

Duloxetine was recalled for containing N-nitroso-duloxetine. This chemical compound includes nitrosamine, a substance known to cause cancer. Nitrosamines are organic compounds that—despite being ...

The bottles contain the "presence" of nitrosamine drug substance impurity, N-nitroso-duloxetine, that exceeds the recommended interim limit, according to the FDA. Rising Pharmaceuticals ...

on November 19, due to the "presence of N-nitroso-duloxetine impurity above recommended interim limit." Duloxetine is an antidepressant medication classified as a serotonin-norepinephrine reuptake ...

The bottles contain the "presence" of nitrosamine drug substance impurity, N-nitroso-duloxetine, that exceeds the recommended interim limit, according to the FDA. Rising Pharmaceuticals, who the FDA ...

and was set as a "class II" risk level by the FDA on Dec. 5. The medication was recalled due to the "presence of N-nitroso-duloxetine impurity above [the] recommended interim limit," the FDA said.

The capsules were sold by New Jersey-based company Rising Pharmaceuticals and contain the "presence" of nitrosamine drug substance impurity, N-nitroso-duloxetine, that exceeds the recommended ...

Rising Pharmaceuticals has voluntarily recalled over 233,000 bottles of Duloxetine in the US due to potential contamination with N-nitroso-duloxetine, a probable carcinogen. The FDA classified the ...